(Clearwisdom.net) On July 24, 2006, Dr. Kirk C. Allison, Associate Director of the Program in Human Rights and Medicine, University of Minnesota issued a statement at the Forum On Stopping the Organ Harvesting in China during the World Transplant Congress held in Boston. The statement, entitled Mounting Evidence of Falun Gong Practitioners used as Organ Sources in China and Related Ethical Responsibilities confirmed the findings in the Report into allegations of Organ Harvesting of Falun Gong Practitioners in China by attorney David Matas and Canadian former Asia-Pacific Secretary of State David Kilgour. The report confirms the high likelihood of Falun Gong practitioners being unwilling organ donors. Dr. Allison stated that academic institutions should review and suspend research collaboration involving transplantation, as well as transplantation data sourced from the People's Republic of China. He said that international transplant patients who obtain organs in China could be doing so at the cost of benefiting from, and tacitly supporting, the continuance of an ongoing lethal violation of human dignity and human rights. Prospective patients should be informed of this fact and be actively discouraged from pursuing this avenue of treatment. The following is the full text of the statement.

Mounting Evidence of Falun Gong Practitioners used as Organ Sources in China and Related Ethical Responsibilities

24 July 2006

Kirk C. Allison, PhD, MS

Associate Director

Program in Human Rights and Medicine

University of Minnesota

The systematic government persecution of nonviolent Falun Gong practitioners in China since July 1999 has constituted the greatest concentration of human rights violations against a single cultural group in China since the cultural revolution. It is a program of suppression separated from conventional judicial processes or appeals. This persecution should cease immediately.

Additionally, there is accumulating convincing evidence of the use of Falun Gong practitioners as involuntary sources for organ transplantation in China. This implies a scope of human rights violations involving institutional medicine not documented since the 1940s. Many recipients of such organs are foreign patients from Malaysia, Japan, Europe and United States.

The 6 July 2006 "Report into allegations of Organ Harvesting of Falun Gong Practitioners in China" by attorney David Matas and Canadian former Asia-Pacific Secretary of State David Kilgour confirms with high likelihood sourcing of Falun Gong organs. Evidence includes interviews and telephone inquiries to specifically identified medical institutions and doctors in China. These interviews identify organs from Falun Gong practitioners as being of high quality, in supply, and usually accessible in a short period of time. This extends concern regarding a system of transplantation already sourced from executed prisoners.

Between 2000 and 2005 the source of some 41,500 organs remains ambiguous. Family donors or nonfamily brain-dead donors account for less than 10 percent of the donations in China. A national voluntary donor program is undeveloped. Kidney transplants nearly tripled in the same period. Liver transplants increased nationwide from about 135 in 1998 to over 4000 in 2005. Various advertised prices ranged widely from about $24,000 (200,000 yuan) for Chinese to $98,000 or more U.S. dollars for foreigners.

Various transplantation websites have promised a liver within an average of one week, a month, or guaranteed by two. A kidney is promised within two weeks, with a second in one week should the first prove "unsuitable." This time frame requires a large pool of donors pretyped for blood group and HLA matching. Systematic blood-testing of arrested Falun Gong practitioners is known. Given a 12-24 hour window for kidney transplantation, and a 12 hour window for liver, scheduled matching cannot be assured on a random-death basis. Heart or whole liver transplantation requires donor death, either prior to or directly by taking the organs.

Recorded telephone inquiries to transplant sites and even detention centers repeatedly identify Falun Gong practitioners as "live", "healthy" and consistently available as sources of organs. Physicians have indicated selecting live prisoners to ensure compatibility.

While reform of the transplantation system has been promised in a new "temporary" regulation taking effect on 1 July 2006, the regulation has not been published verbatim for scrutiny. It reportedly requires that a local hospital ethics committee approve transplants and confirm legal sources. However, there is no indication of less reliance on execution in the transplantation system of China, and certainly no less persecution of Falun Gong.

Given the prominence of the transplantation institutions reflected in the inquiries, it cannot be claimed that such human rights abuses are isolated rogue occasions, unknown or incidental to China's "unique" system of organ procurement. Concern applies both to civilian hospitals ultimately accountable to the Ministry of Health and to military hospitals which are not.

Given a transplantation system relying on executed prisoners generally, and strong evidence of Falun Gong practitioners as sources in particular, the following ethical principles and policy implications apply:

1. An organ transplantation system relying on execution, to which China admits, cannot embody non-coercive informed consent. An option between immediate execution or execution at an arbitrary future time, when blood group type and HLA matches a prospective recipient, makes free, uncoerced, informed consent impossible - if sought at all.

2. The advent of 'organ transplantation tourism' as a source of foreign medical income, and the confluence execution-related organ sourcing and high organ demand increases the likelihood of execution for marginal offenses. Capital offenses in China range from murder, to economic corruption, to nebulous anti-state activity - as leveled against Falun Gong practitioners.

3. What, then, are the human rights responsibilities of the international medical and research community?

a. Professional associations, such as The Transplantation Society, should place a moratorium on research support and collaboration with transplantation in China given that such collaboration tacitly facilitates the continuance of a gross violation of human rights.

b. Academic journals and educational venues, such as the World Transplant Congress, must reject papers and presentations relying on data derived from practices violating standards described in Helsinki Declaration of the World Medical Association Ethical Principles Regarding Medical Research Involving Human Subjects and international instruments.

i. The Helsinki Declaration states: "Concern for the interests of the subject must always prevail over the interests of science and society."

ii. It is unethical to publish research data generated by unethical research processes. Data derived from a transplantation system violating the canons of informed consent clearly falls within this category. This applies to papers based on transplantation data involving procedures where organs are obtained by illicit means. An ethical review of past publications is in order.

iii. It is unethical for tenure or review committees to consider publications or presentations derived from such data as a basis for advancement - despite any technical merit.

iv. While there is a scientific, professional, and even personal cost to ethical and moral consistency, the human rights cost of its generation and underlying practices, and the tendency of after-the-fact legitimation of such data by rationalization and use, is much higher.

1. The publication of unethically generated data, or results based on this data, is also unethical, as it violates the canons of consent. Doing so creates additional demand and allowances for such data, here irrespective of the deaths of nonvoluntary donors.

c. Academic institutions should review and suspend research collaborations involving transplantation, and transplantation data sourced from the Peoples Republic of China. This also applies to practice collaborations or demonstration procedures.

i. While not all transplant surgeons within the Chinese system approve of state practices, the practices in this area are pervasively in violation of fundamental human rights and canons of medical ethics.

d. There is an ethical obligation for funding agencies and foundations to direct or redirect funding to projects with licit sources of data.

4. Given the evidence at hand, international transplant patients who obtain organs in China do so at the cost of benefiting from, and tacitly supporting, the continuance of an ongoing lethal violation of human dignity and human rights. Prospective patients should be informed of this fact and actively discouraged from pursuing this avenue of treatment.

Kirk C. Allison, PhD, MS

Associate Director

Program in Human Rights and Medicine

University of Minnesota